α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
NKT cells are CD1d-restricted innate-like T cells expressing both T cell receptor and NK cell markers. The major group of NKT cells in both human and mice is the invariant NKT (iNKT) cells and the best-known function of iNKT cells is their potent anti-tumor function in mice. Since its discovery 25 y...
Main Authors: | Yingting Zhang, Ryan Springfield, Siyang Chen, Xin Li, Xiaotian Feng, Rosa Moshirian, Rirong Yang, Weiming Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01126/full |
Similar Items
-
Synthesis of a 2ꞌꞌ-Deoxy-β-GalCer
by: Meena S. Thakur, et al.
Published: (2014-07-01) -
Repeated α-GalCer Administration Induces a Type 2 Cytokine-Biased iNKT Cell Response and Exacerbates Atopic Skin Inflammation in Vα14<sup>Tg</sup> NC/Nga Mice
by: Hyun Jung Park, et al.
Published: (2021-11-01) -
Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors
by: Yan-Ruide Li, et al.
Published: (2022-07-01) -
Editorial: NKT Cells in Cancer Immunotherapy
by: Tonya J. Webb, et al.
Published: (2020-06-01) -
Erratum: Editorial: NKT Cells in Cancer Immunotherapy
by: Frontiers Production Office
Published: (2020-08-01)